Topics:

Cross-Border Enrollment of Rare Disease Patients

Inquiries

Summary

Clinical trials in rare diseases present unique challenges unseen in trials for more common conditions. Cross-border enrollment can be key to enrolling and retaining the required number of participants in a rare disease clinical trial. However this creates complex patient logistics and a regulatory maze that must be appropriately navigated. Understanding these considerations is critical to timely and successful study completion.

Register to download

Cross-Border Enrollment of Rare Disease Patients

You may also be interested in:

Rare Diseases Advisory Committee Members page

Rare Diseases Advisory Committee Members

Read More
The Patient Voice: Engaging Rare Disease Patients Improves Clinical Trial Enrollment & Retention White Paper

The Patient Voice: Engaging Rare Disease Patients Improves Clinical Trial Enrollment & Retention

Clinical trials in rare diseases are complex and present unique challenges. However, patients in these trials are very vocal, with caretakers, family…

View Resource
RARE DISEASES NEWSLETTER Volume 7, October 2017 Newsletter

RARE DISEASES NEWSLETTER Volume 7, October 2017

This quarterly publication will keep you up to date on PRA’s Rare Disease Team focus, achievements, and new initiatives.

View Resource

View all related content and resources for Rare Disease

Explore Insights